Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

BACKGROUND: As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate goal of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Adland, Emily, Jesuthasan, Gerald, Downs, Louise, Wharton, Victoria, Wilde, Gemma, McNaughton, Anna L., Collier, Jane, Barnes, Eleanor, Klenerman, Paul, Andersson, Monique, Jeffery, Katie, Matthews, Philippa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137907/
https://www.ncbi.nlm.nih.gov/pubmed/30217169
http://dx.doi.org/10.1186/s12879-018-3367-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137907/
https://www.ncbi.nlm.nih.gov/pubmed/30217169
http://dx.doi.org/10.1186/s12879-018-3367-3

Ejemplares similares